Pfizer XBB.1.5 Monovalent Vaccine Tested in 20 Mice, No Control Group, and No Humans

At this point, the American public and scientific community is flabbergasted at the complete regulatory malfeasance committed by US FDA VRBPAC and CDC panelists. As of September 12, 2023, the prior bivalent (original Wuhan /BA4/BA5 mRNA Code) has been retired and the new XBB.1.5 monovalent vaccines have been emergency use authorized. From the Pfizer core slides released today, there was a single experiment with 10 mice assigned to the prior BA4/BA5 bivalent and 10 assigned to the new XBB.1.5 monovalent vaccine. They were injected twice, 21 days apart. The new booster was authorized for a single 30 mcg shot in humans. ---More...